Valuation: Samsung Biologics Co.,Ltd.

Market Cap 64,622B 43.46B 37.98B 35.05B 32.3B 60.88B 4,185B 62.24B 419B 165B 2,050B 163B 160B 7,056B P/E 2026 *
34.5x
P/E 2027 * 29.2x
Enterprise Value 62.93B 42.32M 36.98M 34.13M 31.46M 59.29M 4.08B 60.61M 408M 160M 2B 159M 155M 6.87B EV / Sales 2026 *
11.7x
EV / Sales 2027 * 9.77x
Free-Float
25.52%
Yield 2026 *
-
Yield 2027 * -
1 day+0.94%
1 week+39.60%
Current month+39.60%
1 month+39.60%
3 months+39.60%
6 months+39.60%
Current year+39.60%
1 week 1,000,000
Extreme 999999.9999
1,408,000
1 month 1,000,000
Extreme 999999.9999
1,408,000
Current year 1,000,000
Extreme 999999.9999
1,408,000
1 year 1,000,000
Extreme 999999.9999
1,408,000
3 years 1,000,000
Extreme 999999.9999
1,408,000
5 years 1,000,000
Extreme 999999.9999
1,408,000
10 years 192,960.76
Extreme 192960.7607
1,408,000
Manager TitleAgeSince
Chief Executive Officer 64 2020-12-08
Director of Finance/CFO 58 2025-03-13
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Chairman 64 2020-12-08
Director/Board Member 72 2022-03-28
Director/Board Member 67 2020-03-19
Date Insider Type Main position Quantity % Market Cap.
12/11/25 Buy

Director

60 0.0001%
12/3/25 Don

Executive/Senior Manager

400 0.0009%
12/2/25 Free 387 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
+0.94%+39.60%+39.60%+39.60% 43.46B
-0.33%+1.83%+23.03%-6.22% 68.85B
+0.67%+0.93%+37.53%+198.53% 52.13B
+1.12%+0.35%-50.35%-52.35% 41.24B
-1.40%+3.43%+60.07%-26.01% 30.41B
-2.11%-9.45%+91.99%-49.58% 24.53B
+0.51%+0.46%+70.08%+91.96% 23.42B
-5.57%-0.84%-0.17%+174.11% 19.75B
-0.86%-1.99%+68.42%+124.39% 16.57B
+1.34%-5.25%+74.11%+154.00% 15.95B
Average -0.57%-1.25%+41.43%+64.84% 33.63B
Weighted average by Cap. -0.26%-0.31%+33.37%+52.29%

Financials

2026 *2027 *
Net sales 5,378B 3.62B 3.16B 2.92B 2.69B 5.07B 348B 5.18B 34.86B 13.71B 171B 13.58B 13.28B 587B 6,288B 4.23B 3.7B 3.41B 3.14B 5.92B 407B 6.06B 40.76B 16.03B 199B 15.88B 15.53B 687B
Net income 1,870B 1.26B 1.1B 1.01B 935M 1.76B 121B 1.8B 12.12B 4.77B 59.31B 4.72B 4.62B 204B 2,209B 1.49B 1.3B 1.2B 1.1B 2.08B 143B 2.13B 14.32B 5.63B 70.07B 5.58B 5.46B 241B
Net Debt -1,691B -1.14B -994M -917M -845M -1.59B -110B -1.63B -10.96B -4.31B -53.65B -4.27B -4.18B -185B -3,163B -2.13B -1.86B -1.72B -1.58B -2.98B -205B -3.05B -20.5B -8.06B -100B -7.99B -7.81B -345B
Logo Samsung Biologics Co.,Ltd.
Samsung Biologics Co Ltd is a Korea-based company primarily engaged in the production of antibody drugs. The Company operates through two segments. The Contract Development and Manufacturing Organization (CDMO) segment primarily provides biopharmaceutical contract manufacturing and cell line development services. The Biopharmaceutical Development and Commercialization segment primarily engages in the development and commercialization of biosimilars.
Employees
5,195
Date Price Change Volume
26-07-16 ₩1,396,000.00 +0.94% 29,974
26-07-15 ₩1,383,000.00 +1.10% 40,849
26-07-14 ₩1,368,000.00 -2.29% 65,068
26-07-13 ₩1,400,000.00 +0.36% 45,614
26-07-10 ₩1,395,000.00 +5.28% 43,685
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
1,396,000.00KRW
Average target price
2,052,158.80KRW
Spread / Average Target
+47.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A207940 Stock